CFTR modulators are the first pharmaceutical class designed specifically to alter the basic defect in CF by either improving the function of CFTR protein present at the cell surface and/or improving the trafficking of the CFTR to the cell surface [20,21]. Here, CFTR is linked to cystic fibrosis.